Home › Calculator › CDNA Dividend Calculator 2026
CDNA Dividend DRIP Calculator 2026
4.00% YieldHealthcareCareDx, Inc · NASDAQ
Price: $50.03 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CDNA pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your CDNA snowball 📈
$10,000 in CDNA → $2.45M in 10 years · $35.18/month
About CareDx, Inc (CDNA) — Dividend Analysis 2026
CareDx, Inc. is a global innovator specializing in the discovery, development, and commercialization of diagnostic and management tools designed for transplant recipients and their healthcare providers. The company's extensive portfolio features a range of specialized diagnostic solutions for organ monitoring, including: AlloSure Kidney, AlloSure Heart, and AlloSure Lung: Advanced tests employing donor-derived cell-free DNA (dd-cfDNA) technology to assess the health of kidney, heart, and lung transplants, respectively. AlloMap Heart: A gene expression-based solution specifically for heart transplant patients. AlloSeq cfDNA: A broader surveillance tool to measure dd-cfDNA levels in the blood. CareDx also provides cutting-edge human leukocyte antigen (HLA) typing technologies, such as TruSight HLA, an NGS-based high-resolution typing solution; Olerup SSP, which uses sequence-specific primer technology for HLA allele typing; QTYPE for precise HLA typing; and AlloSeq Tx, another high-resolution HLA typing offering. For stem cell transplant recipients, the company offers AlloSeq HCT for chimerism testing. Beyond diagnostics, CareDx develops vital software and digital platforms to streamline transplant patient management. These include Ottr, a dedicated transplant patient management software; XynQAPI, focused on transplant quality tracking and waitlist management; and AlloCare, a mobile application serving as a patient-centric resource for those who have undergone transplantation. The company distributes its products directly to clients, as well as through a network of third-party distributors and sub-distributors. CareDx has forged significant partnerships, including a licensing agreement with Illumina, Inc. for the distribution, development, and commercialization of next-generation sequencing (NGS) products and technologies. Additionally, it collaborates with Cibiltech SAS to commercialize iBox, a software designed for the predictive analysis of kidney allograft loss post-transplantation. Founded in 1998, the company was initially known as XDx, Inc. before rebranding to CareDx, Inc. in March 2014. Its headquarters are located in South San Francisco, California.
Compare CDNA with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CDNA DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CDNA position with:
🌍 CDNA Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CDNA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 4.00% | 1.20% | $400 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 3.40% | 0.60% | $340 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 3.20% | 0.40% | $320 / yr |
| 🇬🇧 UK ISA | 0% | 4.00% | 1.20% | $400 / yr |
| 🇬🇧 UK Taxable | 8.75% | 3.65% | 0.85% | $365 / yr |
| 🇨🇦 TFSA | 0% | 4.00% | 1.20% | $400 / yr |
| 🇨🇦 CA Taxable | 25% | 3.00% | 0.20% | $300 / yr |
| 🇦🇺 Super (pension) | 15% | 3.40% | 0.60% | $340 / yr |
| 🇦🇺 AU Taxable | 30% | 2.80% | 0.00% | $280 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2.95% | 0.15% | $295 / yr |
| 🇫🇷 FR Taxable | 30% | 2.80% | 0.00% | $280 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CDNA Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CDNA Dividend Payment Schedule
CDNA pays quarterly — 4 times per year. Next ex-div: TBD.
📊 CDNA vs Healthcare Benchmarks
How CDNA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CDNA sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CDNA Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Sale | 2026-08-05 | 20,000 | $46.28 | $925.7K | ||
| Sale | 2026-08-04 | 16,000 | $46.94 | $751.0K | ||
| Sale | 2026-08-05 | 2,188 | $46.15 | $101.0K | ||
| Sale | 2026-08-05 | 500 | $46.75 | $23.4K | ||
| Sale | 2026-08-04 | 44,700 | $47.06 | $2.10M | ||
| F-InKind | 2026-08-01 | 2,872 | $47.85 | $137.4K | ||
| M-Exempt | 2026-07-16 | 118,000 | $8.20 | $967.6K | ||
| Sale | 2026-07-16 | 50,000 | $36.11 | $1.81M | ||
| Sale | 2026-07-16 | 68,000 | $39.01 | $2.65M | ||
| M-Exempt | 2026-07-16 | 118,000 | $8.20 | $967.6K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where CDNA earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CDNA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
CareDx, Inc (CDNA) is currently trading at $50.03, 46% below its 52-week high. The current dividend yield is 4.00% based on an annual payout of $2.00 per share.
CDNA (CareDx, Inc) — 4.00% Dividend Yield Analysis
CareDx, Inc (CDNA) is a healthcare stock currently trading at $50.03 with a dividend yield of 4.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.